Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by DeathXray33on Aug 26, 2024 5:06pm

RE:RE:RE:RE:266% increase...

"the viral inactivation mediated by TLD-1433-PDT-induced ROS is effective against different families of viruses, not only enveloped but also non-enveloped, via lipid peroxidation and potentially ...more  
116
Discussion
Comment by Mikee3003on Aug 26, 2024 4:12pm

RE:RE:RE:266% increase...

Apparently a foreign group is now working on a combo Kool Aid + Metformin treatment. To date there have been incredible petrie dish results for the treatment of pumpastockatitus. 
94
Discussion
Comment by N0taP00pon Aug 26, 2024 3:30pm

RE:RE:266% increase...

@Mikee3003:  I think the Kool-Aid is almost as potent as Ruvidar. 
72
Discussion
Post by O12009on Aug 26, 2024 3:12pm

Calm before the storm

Someone told me long ago There's a calm before the storm  I know ,it's been coming for sometime 
261
Discussion
Post by DJDawgon Aug 26, 2024 3:10pm

no volume on tsx-v

Interesting day so far. No shares trades on tsx-v. Waiting on some PP updates I guess.
133
Discussion
Comment by Mikee3003on Aug 26, 2024 3:02pm

RE:266% increase...

"OnceTLT-Ruvidar has been approved by the FDA, TLT will push forward with Metformin+Rutherrin to be part the solution for this FDA new big problem, as Metformin+Rutherrin has the potential to ...more  
192
Discussion
Comment by Longholder99on Aug 26, 2024 12:23pm

RE:RE:266% increase...

I'm sure a live animal trial will only take a month to set up, complete, and report on.  Piece of cake.  
108
Discussion
Comment by Tarbabyon Aug 26, 2024 11:07am

RE:266% increase...

So far they have only announced that cancer cell lines in a petrie dish have been destroyed by the Rutherrin/Metformin/xray combo. THATS A GREAT START but for major credibility they need to show that ...more  
176
Discussion
Post by wildbird1on Aug 26, 2024 9:07am

266% increase...

As described in this link... Five reasons why bowel cancer is becoming more common in under 50s -There has been a 266% increase in Bowel Cancer rates among adolescents and young adults over the past ...more  
366
Discussion
Comment by Dumbeldorfwhiteon Aug 26, 2024 9:00am

RE:RE:RE:Question for the board

Because everything to date has shown that the company cannot execute and or provide value to the stock price. I'm sure the people putting huge money in the last pp in 2020 never thought their ...more  
137
Discussion
Comment by Dumbeldorfwhiteon Aug 26, 2024 7:47am

RE:RE:Only 25 days remain Quarter 3 ! 11 shares = xlarge Tim's Cof

Should have read 25 days til another delay.
81
Discussion
Comment by Oden6570on Aug 26, 2024 5:38am

RE:Only 25 days remain Quarter 3 ! 11 shares = xlarge Tim's Cof

Should have read 25 trading days left in 3rd quarter :-)
103
Discussion
Post by Oden6570on Aug 26, 2024 5:35am

Only 25 days remain Quarter 3 ! 11 shares = xlarge Tim's Cof

Break Through Designation Update: In 2020, the FDA granted Theralase® Fast Track Designation ("FTD") for Study II. As a Fast Track designee, Theralase® has access to early and ...more  
245
Discussion
Comment by DJDawgon Aug 25, 2024 8:57pm

RE:RE:RE:Question for the board

Not sure really. I guess this would be math scenario. Lose money at 0.15 Use cash to buy at 0.2 and a warrant at 0.3 that you will have to pay 0.3 to redeem. If someone knows an equation on that you ...more  
174
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250